Annual Shareholders Equity
-$131.40 M
-$57.40 M-77.57%
December 31, 2023
Summary
- As of February 7, 2025, KYTX annual stockholders equity is -$131.40 million, with the most recent change of -$57.40 million (-77.57%) on December 31, 2023.
- During the last 3 years, KYTX annual shareholders equity has fallen by -$85.14 million (-184.08%).
- KYTX annual shareholders equity is now -184.08% below its all-time high of -$46.25 million, reached on December 1, 2021.
Performance
KYTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$302.71 M
-$30.80 M-9.23%
September 30, 2024
Summary
- As of February 7, 2025, KYTX quarterly stockholders equity is $302.71 million, with the most recent change of -$30.80 million (-9.23%) on September 30, 2024.
- Over the past year, KYTX quarterly shareholders equity has increased by +$434.11 million (+330.38%).
- KYTX quarterly shareholders equity is now -16.14% below its all-time high of $360.99 million, reached on March 31, 2024.
Performance
KYTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
KYTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -77.6% | +330.4% |
| 3 y3 years | -184.1% | +330.4% |
| 5 y5 years | -184.1% | +330.4% |
KYTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -184.1% | at low | -16.1% | +330.4% |
| 5 y | 5-year | -184.1% | at low | -16.1% | +330.4% |
| alltime | all time | -184.1% | at low | -16.1% | +330.4% |
Kyverna Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $302.71 M(-9.2%) |
| Jun 2024 | - | $333.51 M(-7.6%) |
| Mar 2024 | - | $360.99 M(-374.7%) |
| Dec 2023 | -$131.40 M | -$131.40 M(+17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$111.81 M(+51.1%) |
| Dec 2022 | -$74.00 M(+60.0%) | - |
| Dec 2022 | - | -$74.00 M |
| Dec 2021 | -$46.25 M | - |
FAQ
- What is Kyverna Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual shareholders equity year-on-year change?
- What is Kyverna Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly shareholders equity year-on-year change?
What is Kyverna Therapeutics annual stockholders equity?
The current annual shareholders equity of KYTX is -$131.40 M
What is the all time high annual shareholders equity for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual stockholders equity is -$46.25 M
What is Kyverna Therapeutics annual shareholders equity year-on-year change?
Over the past year, KYTX annual stockholders equity has changed by -$57.40 M (-77.57%)
What is Kyverna Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of KYTX is $302.71 M
What is the all time high quarterly shareholders equity for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly stockholders equity is $360.99 M
What is Kyverna Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, KYTX quarterly stockholders equity has changed by +$434.11 M (+330.38%)